The system includes information about and analyses of adverse events communicated by healthcare providers, suppliers, and consumers. The goal of this action is to make this information more accessible to the public.
The FDA’s Commissioner, Marty Makary, M.D., M.P.H., said in a press release, “Adverse event reporting should be fast, seamless and transparent. People who navigate the government’s clunky adverse event reporting websites should not have to wait months for that information to become public. We’re closing that waiting period and will continue to streamline the process from start to finish.”
